{
    "medicine_id": "2a425924c15f9e6dde651daab4cdb75fabd88308",
    "platform_id": "DB04963",
    "metadata": {
        "name": "Potiga 50 mg 1 Tablet film coated",
        "composition": "50 mg 1 rhGAD65",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in diabetes mellitus type 1",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The immune system of patients treated with rhGAD65 demonstrate an increase in the secretion of several immunomodulatory substances dominated by regulatory cytokines including IL5 IL13 IL10 IL17 IFN a and TNF a Additionally the activity of T cells in response to GAD65 is increased with rhGAD65 therapy and subjects receiving rhGAD65 show an up regulation of cytokines in response to GAD65",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}